Solara Active Pharma Sciences informs about transcript of conference call

21 Feb 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Solara Active Pharma Sciences has informed that it enclosed the transcript of the earnings conference call for the quarter ended December 31, 2023, conducted after the meeting of Board of Directors held on February 14, 2024. The above information is also available on the website of Company at https://solara.co.in/investorrelations/investor-update.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

509.40 -24.55 (-4.60%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...